These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 34239686)
1. Wogonin Strengthens the Therapeutic Effects of Mesenchymal Stem Cells in DSS-Induced Colitis via Promoting IL-10 Production. Wu Q; Xie S; Zhu Y; Chen J; Tian J; Xiong S; Wu C; Ye Y; Peng Y Oxid Med Cell Longev; 2021; 2021():5527935. PubMed ID: 34239686 [TBL] [Abstract][Full Text] [Related]
2. Wogonin preconditioning of MSCs improved their therapeutic efficiency for colitis through promoting glycolysis. Wu M; Li C; Zhou X; Wu Z; Feng J; Guo X; Fang R; Lian Q; Pan M; Lai X; Peng Y Inflammopharmacology; 2024 Aug; 32(4):2575-2587. PubMed ID: 38753221 [TBL] [Abstract][Full Text] [Related]
3. The NLRP3 molecule influences the therapeutic effects of mesenchymal stem cells through Glut1-mediated energy metabolic reprogramming. Chen J; Xie S; Qiu D; Xie M; Wu M; Li X; Zhang X; Wu Q; Xiong Y; Wu C; Ren J; Peng Y J Adv Res; 2024 Nov; 65():125-136. PubMed ID: 38070595 [TBL] [Abstract][Full Text] [Related]
4. Wogonin Suppresses IL-10 Production in B Cells via STAT3 and ERK Signaling Pathway. Fan L; Qiu D; Huang G; Chen J; Wu Q; Xiong S; Wu C; Peng Y; Zhang Q J Immunol Res; 2020; 2020():3032425. PubMed ID: 32566686 [TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922 [TBL] [Abstract][Full Text] [Related]
6. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens. Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680 [TBL] [Abstract][Full Text] [Related]
7. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice. Jo H; Eom YW; Kim HS; Park HJ; Kim HM; Cho MY Gut Liver; 2018 Nov; 12(6):664-673. PubMed ID: 29938461 [TBL] [Abstract][Full Text] [Related]
8. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice. Song WJ; Li Q; Ryu MO; Nam A; An JH; Jung YC; Ahn JO; Youn HY Res Vet Sci; 2019 Aug; 125():176-184. PubMed ID: 31247473 [TBL] [Abstract][Full Text] [Related]
9. Intraperitoneally Delivered Mesenchymal Stem Cells Alleviate Experimental Colitis Through THBS1-Mediated Induction of IL-10-Competent Regulatory B Cells. Liu J; Lai X; Bao Y; Xie W; Li Z; Chen J; Li G; Wang T; Huang W; Ma Y; Shi J; Zhao E; Xiang AP; Liu Q; Chen X Front Immunol; 2022; 13():853894. PubMed ID: 35371051 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis. Legaki E; Roubelakis MG; Theodoropoulos GE; Lazaris A; Kollia A; Karamanolis G; Marinos E; Gazouli M Stem Cell Rev Rep; 2016 Oct; 12(5):604-612. PubMed ID: 27503204 [TBL] [Abstract][Full Text] [Related]
11. Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis. Barnhoorn M; de Jonge-Muller E; Molendijk I; van Gulijk M; Lebbink O; Janson S; Schoonderwoerd M; van der Helm D; van der Meulen-de Jong A; Hawinkels L; Verspaget H Inflamm Bowel Dis; 2018 Jul; 24(8):1755-1767. PubMed ID: 29796655 [TBL] [Abstract][Full Text] [Related]
12. TNFα and IFNγ rapidly activate PI3K-AKT signaling to drive glycolysis that confers mesenchymal stem cells enhanced anti-inflammatory property. Xu C; Feng C; Huang P; Li Y; Liu R; Liu C; Han Y; Chen L; Ding Y; Shao C; Shi Y Stem Cell Res Ther; 2022 Oct; 13(1):491. PubMed ID: 36195887 [TBL] [Abstract][Full Text] [Related]
13. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu. Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS Front Immunol; 2018; 9():1078. PubMed ID: 29892282 [TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal administration of mesenchymal stem cells ameliorates acute dextran sulfate sodium-induced colitis by suppressing dendritic cells. Nikolic A; Simovic Markovic B; Gazdic M; Randall Harrell C; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; L Lukic M; Stojkovic M; Volarevic V Biomed Pharmacother; 2018 Apr; 100():426-432. PubMed ID: 29471245 [TBL] [Abstract][Full Text] [Related]
15. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. He XW; He XS; Lian L; Wu XJ; Lan P Dig Dis Sci; 2012 Dec; 57(12):3136-44. PubMed ID: 22752635 [TBL] [Abstract][Full Text] [Related]
16. Dual-Functionalized MSCs that Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease. Fu Y; Ni J; Chen J; Ma G; Zhao M; Zhu S; Shi T; Zhu J; Huang Z; Zhang J; Chen J Mol Ther; 2020 Apr; 28(4):1214-1228. PubMed ID: 32087149 [TBL] [Abstract][Full Text] [Related]
17. High-dose wogonin exacerbates DSS-induced colitis by up-regulating effector T cell function and inhibiting Treg cell. Xiao W; Yin M; Wu K; Lu G; Deng B; Zhang Y; Qian L; Jia X; Ding Y; Gong W J Cell Mol Med; 2017 Feb; 21(2):286-298. PubMed ID: 27641629 [TBL] [Abstract][Full Text] [Related]
18. The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis. Heidari M; Pouya S; Baghaei K; Aghdaei HA; Namaki S; Zali MR; Hashemi SM J Cell Physiol; 2018 Nov; 233(11):8754-8766. PubMed ID: 29797577 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E An JH; Song WJ; Li Q; Kim SM; Yang JI; Ryu MO; Nam AR; Bhang DH; Jung YC; Youn HY BMC Vet Res; 2018 Nov; 14(1):354. PubMed ID: 30453939 [TBL] [Abstract][Full Text] [Related]
20. The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase. Lim JY; Kim BS; Ryu DB; Kim TW; Park G; Min CK Stem Cell Res Ther; 2021 Jan; 12(1):37. PubMed ID: 33413597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]